We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Philip J. (P.J.) Brooks, PhD

Philip J. (P.J.) Brooks, PhD

Deputy Director

 at National Institutes of Health

Philip J. (P.J.) Brooks is the deputy director of NCATS’ Division of Rare Diseases Research Innovation. He also is the working group co-coordinator for the NIH Common Fund program on Somatic Cell Genome Editing, one of the leaders of the Platform Vector Gene Therapy (PaVe-GT) pilot project and the co-chair of the Bespoke Gene Therapy Consortium(link is external). He also represents NCATS in the International Rare Diseases Research Consortium (IRDiRC). In May 2022, Brooks was selected as the recipient of the 2022 Sonia Skarlatos Public Service Award(link is external) by the American Society of Gene & Cell Therapy for consistently fostering and enhancing the field of gene and cell therapy. Brooks received his doctorate in neurobiology from The University of North Carolina at Chapel Hill. After completing a postdoctoral fellowship at The Rockefeller University, he became an investigator in the NIH intramural program, where he developed an internationally recognized research program focused on two distinct areas: the molecular basis of alcohol-related cancer, and rare neurologic diseases resulting from defective DNA repair, including xeroderma pigmentosum, Cockayne syndrome and Fanconi anemia.

Got a question for Philip J. (P.J.) Brooks, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly